SVB Leerink reiterated coverage on Clover Health Investments with a new price target
$CLOV
Medical Specialities
Health Care
SVB Leerink reiterated coverage of Clover Health Investments with a rating of Market Perform and set a new price target of $2.50 from $3.00 previously